LC-MS/MS Performance Data for Clinical Lab Leaders

	Clinical & Point-of-Care Diagnostics
	Testing platforms for decentralized, near-patient, and critical care applications

Clinical lab managers need reliable performance data to support confident decisions. The Citrine system compendium showcases 22 analytical performance datasheets across steroids, vitamins, biomarkers, therapeutic drugs, and toxicology. See how streamlined LC‑MS/MS workflows can improve consistency, efficiency, and confidence in routine clinical testing.

Download the Citrine System Compendium

Event guide: World Clinical Biomarkers & CDx Summit Japan

Japan’s biomarker and companion diagnostics (CDx) landscape is moving quickly. As regulatory frameworks mature and CDx co-development gains stronger institutional support, we’re seeing real momentum in precision oncology.

Acess the Full Event Guide

Combined GLP-1 and GLP-2 treatment appears safe but does not beat placebo for obesity

In a 12-week randomized phase IIa trial in adults with obesity, the dual GLP-1/GLP-2 receptor agonist dapiglutide was well tolerated but did not achieve statistically significant weight loss compared with placebo at 4 mg or 6 mg doses. Although the higher dose showed modest within-group weight reduction and improved HbA1c, unexpectedly substantial placebo-associated weight loss limited the observed treatment effect.

	Researchers develop DNA aptamer to detect Alzheimer's biomarkers With aging populations on the rise, the need for better tools to diagnose and monitor Alzheimer's disease (AD), the most common cause of dementia, has never been more urgent.

	Detecting major neurological disorders via saliva A team of Korean researchers has, for the first time in the world, developed a technology capable of enabling early diagnosis of major neurological disorders, including epilepsy, Parkinson's disease, and schizophrenia, using only a small amount of saliva.

	Researchers develop versatile machine learning tool to automate complex clinical diagnostics A research team funded by the National Institutes of Health (NIH) has developed a versatile machine learning model that could one day greatly expand what medical scans can tell us about disease.

	Wisdom Bioscience establishes Scientific Advisory Board to advance oral cancer diagnostics and screening Wisdom Bioscience, Inc., a biotechnology company pioneering non-invasive oral cancer diagnostics, today announced the formation of its Scientific Advisory Board (SAB) following the close of an initial funding round.

	Key PABS annex negotiations for WHO Pandemic Agreement near completion Member States of the World Health Organization (WHO) concluded a weeklong round of negotiations on draft annex for Pathogen Access and Benefit Sharing (PABS) – a key component of the WHO Pandemic Agreement.

	Combining gene and biomarker screening for newborn health For more than six decades, biomarker-based newborn screening has played a pivotal role in reducing infant mortality and long-term disability by enabling early detection of metabolic and endocrine disorders.

	Single blood test predicts onset of Alzheimer’s symptoms years ahead Researchers at Washington University School of Medicine in St. Louis have developed a method to predict when someone is likely to develop symptoms of Alzheimer's disease using a single blood test.

How would you rate today's newsletter?

Stay updated with the latest in health and medical news! Follow News‑Medical.net on Google News for real‑time updates. Click here to follow us now.

Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd.,

Manchester | Sydney | Boston

Copyright © 2000-2026